Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry
Press Releases
New clinical research highlights AI-driven gains in aneurysm detection, stroke interpretation, and enterprise imaging efficiency.
Building on FDA clearances, enterprise AI leadership, and global expansion, RapidAI and AWS are advancing secure, scalable AI that transforms imaging AI
New clearances expand the Rapid Enterprise Platform, advancing radiology precision, and elevating neurology and vascular care through deep clinical AI
Healthcare Business Today
Forbes
NeuroNews International
1783814400000
Events
1784505600000
Blog
AI healthcare platforms need clinical validation, workflow fit, and governance. Health systems should evaluate vendors beyond the demo.
Frost & Sullivan's 2026 Radar highlights RapidAI's leadership in intelligent imaging AI, emphasizing the shift towards enterprise-wide integration and predictive capabilities.
CT perfusion in stroke care significantly increases treatment rates for patients, especially those with medium vessel occlusions, without causing delays.
